Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue growth thanks to the fact that patients need their medicines -- so will ...

Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

CVS Health's shares have climbed sharply this year, largely due to much-improved results. The company is still dealing with some headwinds, but it has a plan to address them. CVS Health's diversified ...

Teva Pharmaceutical (TEVA) is trading at new 5-year highs. ・Shares are up more than 40% over the past year. ・The stock has ...

Royalty Pharma has acquired PTC's remaining royalty on Roche's Evrysdi for $240 million upfront and sales-based milestones.

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Guardian Pharmacy Services (GRDN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter. Guardian's third quarter prominently ...